---
document_datetime: 2024-09-24 12:15:13
document_pages: 7
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/entacapone-orion-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: entacapone-orion-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 4.2888673
conversion_datetime: 2025-12-18 22:24:50.895306
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Entacapone Orion

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                            | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                           |
|----------------------|--------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------------------------------|
| N/0023               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 20/09/2024                          |                                             | PL                               |                                   |
| PSUSA/1223/ 202201   | Periodic Safety Update EU Single assessment - entacapone                                         | 01/09/2022                          | n/a                                         |                                  | PRAC Recommendation - maintenance |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| WS/2202/G   | This was an application for a group of variations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.z - Quality change - Active substance - Other variation B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation   | 31/03/2022   | n/a        |                        |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|
| WS/2096     | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 21/10/2021   | 14/10/2022 | SmPC, Labelling and PL |
| IG/1277     | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 08/10/2020   | 29/09/2021 | Annex II and PL        |

<div style=\"page-break-after: always\"></div>

| WS/1735/G          | This was an application for a group of variations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.d.1.b.3 - Stability of AS - Change in the storage conditions - Change in storage conditions of the AS B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF   | 12/03/2020   | n/a        |    |                                   |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----|-----------------------------------|
| PSUSA/1223/ 201901 | Periodic Safety Update EU Single assessment - entacapone                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 05/09/2019   | n/a        |    | PRAC Recommendation - maintenance |
| N/0017             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 30/08/2019   | 29/09/2021 | PL |                                   |
| IG/0982/G          | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for                                                                                                                                              | 26/10/2018   | n/a        |    |                                   |

<div style=\"page-break-after: always\"></div>

|                    | the AS -replacement or addition of a site where batch control/testing takes place                                                                                                                                                            |            |            |                                  |                                                                                                                                                                                                                                                                                |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IG/0888            | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                | 29/01/2018 | n/a        |                                  |                                                                                                                                                                                                                                                                                |
| WS/1064            | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation | 15/12/2016 | 28/11/2017 | SmPC, Annex II, Labelling and PL |                                                                                                                                                                                                                                                                                |
| PSUSA/1223/ 201601 | Periodic Safety Update EU Single assessment - entacapone                                                                                                                                                                                     | 02/09/2016 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                              |
| R/0011             | Renewal of the marketing authorisation.                                                                                                                                                                                                      | 25/02/2016 | 08/04/2016 |                                  | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Entacapone Orion in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| N/0010             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                             | 29/09/2015 | 25/01/2016 | PL                               |                                                                                                                                                                                                                                                                                |
| IG/0546            | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                              | 27/04/2015 | n/a        |                                  |                                                                                                                                                                                                                                                                                |
| WS/0665            | This was an application for a variation following a worksharing procedure according to Article 20 of                                                                                                                                         | 22/01/2015 | 25/01/2016 | SmPC, Labelling and              |                                                                                                                                                                                                                                                                                |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | Commission Regulation (EC) No 1234/2008. To update the Product Information as follows: - to include ADR statement - to update the PI to QRD template version 9 - to include an explanation to the PL of the pictogram which is currently only displayed on the carton (all products except Comtan) - to correct the local contact information for Malta in Stalevo PL - to correct the local contact information for Latvia in all PLs except for Comtan and Entacapone Orion - to correct the local contact information for Germany in Comtess and Levodopa/Carbidopa/Entacapone Orion - for Comtan only: to add 'Magnesium stearate' to the list of excipients for the film-coating in the SmPC and PL. Tablet core and Film-coating both contain magnesium stearate - to correct linguistic amendments in Annexes - to amend a mistake in the Annex A (only for Comtan). C.I.z - Changes (Safety/Efficacy) of Human and   |            |     | PL   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------|
| IG/0433/G | This was an application for a group of variations. B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.1.a - Replacement or addition of a                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 08/05/2014 | n/a |      |

<div style=\"page-break-after: always\"></div>

|         | manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                                                             |            |            |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| N/0006  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                     | 19/08/2013 | 25/01/2016 | PL                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| WS/0331 | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. Update of SmPC sections 4.4 and 4.8 in order to update the safety information by implementing class labelling for the risk of impulse control disorders. C.I.3.z - Implementation of change(s) requested following the assessment of an USR, class labelling, a PSUR, RMP, FUM/SO, data submitted under A 45/46, or amendments to reflect a Core SPC - Other variation | 13/12/2012 | 14/01/2013 | SmPC, Annex II, Labelling and PL | Based on a recent review of the available post-marketing data in relation to the risk of development of impulse control disorders when using medicinal products containing levodopa, dopamine agonists and/or catechol-O- methyltransferase (COMT) inhibitors, the CHMP/PhVWP requested a class labelling to update and harmonise the product information of all products concerned. In response to this request, the product information was updated to reflect behavioural symptoms related to impulse control disorders including compulsive spending or buying, binge eating and compulsive eating. It was clarified that this adverse reaction can occur irrespective of the indication and at normal doses. Furthermore, regular monitoring of patients and a careful review of treatment, if symptoms occur, is recommended. The Package Leaflet was updated in accordance and advice for the patient's family and carers was provided. |
| N/0004  | The Marketing Authorisation Holder (MAH) took the opportunity to update details of local representatives in Annex IIIB. Furthermore, incorrect package sizes were corrected in section 6 of the Portugese package leaflet. Minor change in labelling or package leaflet not                                                                                                                                                                                                                                          | 11/07/2012 | 14/01/2013 | PL                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

<div style=\"page-break-after: always\"></div>

| N/0003   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                   | 20/03/2012   | 14/01/2013   | PL   |                   |
|----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------|-------------------|
| WS/0199  | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.III.2.a.1 - Change of specification('s) of a former non Pharmacopoeial substance to comply with the Ph. Eur. or with a national pharmacopoeia of a | 19/01/2012   | 19/01/2012   |      | Member State - AS |
| IG/0110  | C.I.9.i - Changes to an existing pharmacovigilance system as described in the DDPS - Change(s) to a DDPS following the assessment of the same DDPS in relation to another medicinal product of the same MAH                                                                                        | 04/10/2011   | n/a          |      |                   |